Parkinson's disease affects men roughly 1.5 times more often than women, yet most neurological research has historically ignored sex as a biological variable. A new framework emerging from single-cell genomics may finally explain why — and the answer lies not just in dopaminergic neurons but in the immune and support cells surrounding them.
This review synthesizes findings from single-cell RNA-sequencing (scRNA-seq) studies of Parkinson's disease, cataloguing how individual cell populations behave differently from bulk-tissue averages. The technology isolates gene expression at the resolution of single neurons, microglia, and oligodendrocytes, revealing disease-associated subpopulations invisible to conventional methods. Key findings highlighted include the disproportionate vulnerability of specific dopaminergic neuron subtypes, dysregulated intercellular signaling networks implicating microglia in neuroinflammatory cascades, and oligodendrocyte dysfunction that may compromise myelin integrity before overt motor symptoms emerge. Critically, the review flags emerging sex-stratified transcriptomic signatures suggesting that the molecular choreography of neurodegeneration differs between male and female tissue — a distinction that bulk sequencing was too coarse to detect.
The broader significance here is methodological and conceptual simultaneously. For decades, Parkinson's research treated the substantia nigra as a relatively uniform structure undergoing uniform decline. Single-cell resolution dismantles that assumption entirely, and the sex-specificity dimension adds another layer of complexity that therapeutic pipelines have yet to seriously address. Most existing scRNA-seq PD datasets are underpowered for sex-stratified analysis, meaning current findings remain preliminary and replication in larger, prospectively sex-balanced cohorts is essential. The practical implication for longevity-conscious readers is indirect but meaningful: if microglial activation patterns and oligodendrocyte stress responses differ by sex, then neuroprotective strategies — dietary, pharmacological, or lifestyle-based — may ultimately need to be tailored accordingly. This review positions sex-aware single-cell design as a prerequisite for the next generation of precision neurology rather than an optional refinement.